HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

PI-2620

Also Known As:

11-(2-fluoranylpyridin-4-yl)-4,8,10-triazatricyclo(7.4.0.02,7)trideca-1(9),2(7),3,5,10,12-hexaene

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - PI-2620: 1

Experts

1.	Berndt, Mathias: 1 article (01/2021)
2.	Capotosti, Francesca: 1 article (01/2021)
3.	Dinkelborg, Ludger: 1 article (01/2021)
4.	Gabellieri, Emanuele: 1 article (01/2021)
5.	Hickman, David: 1 article (01/2021)
6.	Kroth, Heiko: 1 article (01/2021)
7.	Molette, Jerome: 1 article (01/2021)
8.	Mueller, Andre: 1 article (01/2021)
9.	Oden, Felix: 1 article (01/2021)
10.	Pfeifer, Andrea: 1 article (01/2021)

Related Diseases

1.	Tauopathies 01/01/2021 - "PI-2620 Lead Optimization Highlights the Importance of Off-Target Assays to Develop a PET Tracer for the Detection of Pathological Aggregated Tau in Alzheimer's Disease and Other Tauopathies."
2.	Pick Disease of the Brain (Pick's Disease) 01/01/2021 - "Furthermore, PI-2620 showed Tau binding on brain sections from corticobasal degeneration, progressive supranuclear palsy, and Pick's disease."
3.	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/01/2021 - "Furthermore, PI-2620 showed Tau binding on brain sections from corticobasal degeneration, progressive supranuclear palsy, and Pick's disease."
4.	Alzheimer Disease (Alzheimer's Disease) 01/01/2021 - "PI-2620 Lead Optimization Highlights the Importance of Off-Target Assays to Develop a PET Tracer for the Detection of Pathological Aggregated Tau in Alzheimer's Disease and Other Tauopathies."
5.	Corticobasal Degeneration 01/01/2021 - "Furthermore, PI-2620 showed Tau binding on brain sections from corticobasal degeneration, progressive supranuclear palsy, and Pick's disease."